US2005033044A1PendingUtilityA1
Methods for preparing 2-alkynyladenosine derivatives
Assignee: BRISTOL MYERS SQUIBB PHARMA COPriority: May 19, 2003Filed: May 18, 2004Published: Feb 10, 2005
Est. expiryMay 19, 2023(expired)· nominal 20-yr term from priority
C07H 19/16
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are methods for preparing 2-alkynyladenosine derivatives of formula A: or a stereoisomer, pharmaceutically acceptable salt, hydrate, solvate, acid salt hydrate or isomorphic crystalline form thereof, the method comprising the step of: contacting 2-iodoadenosine-5′-N-ethyluronamide with a compound of formula B: wherein Z is —C(═O)OR or —CH 2 OC(═O)R, where R is a C 1 to C 5 alkyl, preferably methyl. The methods are useful for preparing 2-alkynyladenosine derivatives that are, in certain embodiments, adenosine receptor agonists.
Claims
exact text as granted — not AI-modified1 . A method for preparing a compound of formula A:
or a stereoisomer, pharmaceutically acceptable salt, hydrate, solvate, acid salt hydrate or isomorphic crystalline form thereof, the method comprising the step of:
contacting 2-iodoadenosine-5′-N-ethyluronamide with a compound of formula B:
wherein Z is —C(═O)OR or —CH 2 OC(═O)R, where R is a C 1 to C 5 alkyl.
2 . A method according to claim 1 , wherein Z is —C(═O)OCH 3 or —CH 2 OC(═O)CH 3 .
3 . A method according to claim 1 , wherein said 2-iodoadenosine-5′-N-ethyluronamide is prepared from 2-iodoadenosine.
4 . A method according to claim 3 , further comprising the step of converting said 2-iodoadenosine to the acetonide-protected form of said 2-iodoadenosine of the formula:
5 . A method according to claim 4 , further comprising the step of oxidizing said acetonide-protected form of said 2-iodoadenosine to a compound of the formula:
6 . A method according to claim 5 , wherein said oxidizing step is a radical oxidation.
7 . A method according to claim 5 , wherein said oxidizing step comprises the use of a mixture comprising bis-acetoxyiodobenzene and 2,2,6,6-tetramethyl piperidinyloxy free radical (TEMPO).
8 . A method according to claim 5 , further comprising the step of converting said compound of the formula:
to a compound of the formula:
9 . A method according to claim 8 , wherein said converting step proceeds as a one pot reaction.
10 . A method according to claim 8 , wherein said converting step comprises the use of a succinimide derivative and an excess of ethylamine.
11 . A method according to claim 8 , wherein said converting step comprises the use of a composition comprising 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline, ethanol and ethylamine.
12 . A method according to claim 8 , further comprising the step of deprotecting said compound of the formula:
to form said 2-iodoadenosine-5′-N-ethyluronamide.
13 . A method according to claim 1 , wherein said compound of formula B is prepared from 1,4-methanol cyclohexane.
14 . A method according to claim 13 , wherein said 1,4-methanol cyclohexane is prepared from a reaction mixture comprising trans-1,4-dimethyl-cyclohexanedicarboxylate.
15 . A method according to claim 14 , wherein said reaction mixture comprises less than about 0.2% by weight, based on the total weight of the 1,4-dimethyl-cyclohexanedicarboxylate, of cis-1,4-dimethyl-cyclohexanedicarboxylate.
16 . A method according to claim 13 , wherein said 1,4-methanol cyclohexane is prepared by a process comprising the step of reducing 1,4-dimethyl-cyclohexanedicarboxylate.
17 . A method according to claim 13 , further comprising the step of preparing the mono-tosyl derivative of said 1,4-methanol cyclohexane.
18 . A method according to claim 17 , further comprising the step of acetylide substitution of said tosyl derivative of the formula:
to form an acetylide-substituted compound of the formula:
19 . A method according to claim 18 , further comprising the step of converting said acetylide-substituted compound to a compound of formula B, where Z is —CH 2 OC(═O)R.
20 . A method according to claim 18 , further comprising the steps of oxidizing said acetylide-substituted compound and esterifying said product of said oxidation to a compound of formula B, where Z is —C(═O)OR.
21 . A method for preparing 2-iodoadenosine-5′-N-ethyluronamide, comprising the steps of:
providing 2-iodoadenosine; protecting the hydroxyl groups of said 2-iodoadenosine with an acetonide group; oxidizing the primary alcohol of said acetonide-protected 2-iodoadenosine to an acid derivative of said acetonide-protected 2-iodoadenosine; converting said acid derivative to an N-ethylamide derivative of said acetonide-protected 2-iodoadenosine; and deprotecting said N-ethylamide of said acetonide-protected 2-iodoadenosine to form said 2-iodoadenosine-5′-N-ethyluronamide.
22 . A method for preparing a compound of formula B:
wherein Z is —CH 2 OC(═O)R, where R is a C 1 to C 5 alkyl, comprising the steps of.
providing 1,4-methanol cyclohexane; and
preparing a mono-tosyl derivative of said 1,4-methanol cyclohexane;
preparing an acetylide-substituted compound of the formula:
from said mono-tosyl derivative of said 1,4-methanol cyclohexane; and
converting said acetylide-substituted compound to a compound of formula B:
23 . A method for preparing a compound of formula B:
wherein Z is —C(═O)OR, where R is a C 1 to C 5 alkyl, comprising the steps of.
providing 1,4-methanol cyclohexane;
preparing a mono-tosyl derivative of said 1,4-methanol cyclohexane;
preparing an acetylide-substituted compound of the formula:
from said mono-tosyl derivative of said 1,4-methanol cyclohexane;
oxidizing said acetylide-substituted compound using radical oxidation; and
esterifying said product of said oxidation to a compound of formula B:
24 . A method according to claim 23 , wherein said oxidizing step comprises the use of a mixture comprising bis-acetoxyiodobenzene and 2,2,6,6-tetramethyl piperidinyloxy free radical (TEMPO).
25 . A method according to claim 22 or claim 23 , wherein said 1,4-methanol cyclohexane is prepared from a reaction mixture comprising trans-1,4-dimethyl-cyclohexanedicarboxylate.
26 . A method according to claim 25 , wherein said reaction mixture comprises less than about 0.2% by weight, based on the total weight of the 1,4-dimethyl-cyclohexanedicarboxylate, of cis-1,4-dimethyl-cyclohexanedicarboxylate.
27 . A method according to claim 22 or claim 23 , wherein said 1,4-methanol cyclohexane is prepared by a process comprising the step of reducing 1,4-dimethyl-cyclohexanedicarboxylate.Join the waitlist — get patent alerts
Track US2005033044A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.